Global Health Progress

Over the past 48 hours, news has broken in India of the existence of at least 12 patients infected with tuberculosis that has become resistant to all the drugs used against the disease.

Harvard International Law Journal
Kristina M. Lybecker
An Article from the Symposium: Developments and Challenges in International Intellectual Property Law
Each year more than eighteen million human lives end in death from poverty-related causes, fully one-third of all human deaths globally. This amounts to fifty thousand deaths per day from causes such as respiratory infections, HIV/AIDS, tuberculosis, malaria, [...]

Drugmakers Pfizer and GlaxoSmithKline announced Friday they have agreed to supply hundreds of millions of additional doses of pneumonia vaccine to an international partnership that provides immunization to children in developing countries.

The fourth G-FINDER survey reports on 2010 global investment into research and development (R&D) of new products for neglected diseases, and identifies trends and patterns across the four years of global G-FINDER data.

Despite difficulties in compiling the statistics, there is a clear, and welcome, downward trend in deaths. It is estimated that malaria killed 655,000 people in 2010, compared to 800,000 in 2004.

30 NOVEMBER 2011 | GENEVA – Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term. The latest report by the WHO, UNICEF and UNAIDS Report on the global HIV/AIDS response indicates that increased access to HIV services resulted in a 15% reduction of new infections over the past decade and a 22% decline in AIDS-related deaths in the last five years.

ATLANTA (October 31, 2011) – In an effort to reach the certification of the eradication of Guinea worm in Côte d’Ivoire, a contingent of officials from the World Health Organization Afro and the Ministry of Health have paid a visit to MAP International Côte d’Ivoire office. The objective of this visit was to express appreciation [...]

LILLE, France, October 27, 2011 /PRNewswire/ –
- Funding Continues Partnership’s Fight against
Multidrug-Resistant Tuberculosis
The Eli Lilly and Company Foundation has committed US $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug-resistant tuberculosis – a disease that disproportionately affects developing countries and kills more than 150,000 people each year. The [...]

GENEVA, October 26, 2011 – The World Intellectual Property Organization (WIPO), in an unprecedented collaboration with leading pharmaceutical companies and BIO Ventures for Global Health (BVGH), launched today WIPO Re:Search, a new consortium where public and private sector organizations share valuable intellectual property (IP) and expertise with the global health research community to promote development [...]

Today, on World Polio Day, USAID joins with countries and organizations working diligently around the world to eradicate polio by recognizing the unflagging dedication of health workers, laboratory technicians, community organizations, and volunteers. Their efforts have led to a remarkable 99 percent reduction in cases, seen the elimination of one of the three types of [...]